Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corteva (DE:2X0)
XETRA:2X0
Corteva (2X0) Stock Price & Analysis
3 Followers
2X0 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€39.93 - €54.00
Previous Close€53
Volume16.00
Average Volume (3M)206.00
Market Cap
€36.99B
Enterprise Value€39.97B
Total Cash (Recent Filing)$2.62B
Total Debt (Recent Filing)$5.58B
Price to Earnings (P/E)N/A
Beta0.54
Next Earnings
Aug 01, 2024EPS Estimate
€1.71Next Dividend Ex-DateN/A
Dividend Yield1.1%
Share Statistics
EPS (TTM)N/A
Shares Outstanding696,976,000
10 Day Avg. Volume213
30 Day Avg. Volume206
Standard Deviation0.07
R-Squared0.08
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)7.21
Price to Sales (P/S)7.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.28
Enterprise Value/Gross Profit18.91
Enterprise Value/Ebitda31.90
Forecast
1Y Price Target
€59.32Price Target Upside11.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Corteva News
Bulls Say, Bears Say
Bulls Say
Company RatingAnalyst maintains an Overweight rating on CTVA and increases the Price Target indicating confidence in the stock.
Earnings GoalsCTVA's reaffirmation of 2024 targets reflects confidence in volume growth and ability to meet 2025 earnings goals.
Regulatory EnvironmentEU's ag policy pivot in favor of gene editing could significantly benefit Corteva's advanced breeding techniques.
Bears Say
Financial GuidanceCorteva's earnings guidance for 2024 is ambitious, with the company needing to achieve a significant EBITDA in the second quarter which it has never done before.
Market DemandCrop chemical prices are moving lower and customers are delaying purchases, potentially leading to a slow start for Corteva.
Stock ValuationCorteva's share price is already close to the targeted price, leaving limited upside potential based on current EBITDA expectations.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
4.38% Other Institutional Investors
95.62% Public Companies and
Individual Investors
2X0 FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was €39.93 and its highest was €54.00 in the past 12 months.
What is Corteva’s market cap?
Currently, no data Available
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is Aug 01, 2024 which is in 87 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on May 01, 2024. The company reported €0.831 earnings per share for the quarter, beating the consensus estimate of €0.768 by €0.063.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva does not currently pay dividends.
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is €1.71.
How many shares outstanding does Corteva have?
Currently, no data Available
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of €0.831 in its last earnings report, beating expectations of €0.768. Following the earnings report the stock price went up 6.943%.
Which hedge fund is a major shareholder of Corteva?
Among the largest hedge funds holding Corteva’s share is Independent Franchise Partners Llp. It holds Corteva’s shares valued at 589M.
---
Corteva Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€59.32 (11.92% Upside)
€59.32 (11.92% Upside)
Blogger Sentiment
Bullish
DE:2X0 Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.55%
12-Months-Change
Fundamentals
Return on Equity
2.77%
Trailing 12-Months
Asset Growth
-4.12%
Trailing 12-Months
Company Description
Corteva
Corteva, Inc. is an agricultural chemical and seed company. It develops and supplies advanced germplasm and traits that helps in maximizing yield for farms. It also supplies products that enhances enhance crop health and protectagainst weeds, insects and other pests, and diseases.
---
2X0 Company Deck
---
2X0 Earnings Call
Q1 2024
0:00 / 0:00
---
2X0 Stock 12 Months Forecast
Average Price Target
€59.32
▲(11.92% Upside)
Technical Analysis
Best Analysts Covering 2X0
1 Year
1 Year Success Rate
23/29 ratings generated profit
1 Year Average Return
+14.90%
reiterated a buy rating 6 days ago
Copying Arun Viswanathan's trades and holding each position for 1 Year would result in 79.31% of your transactions generating a profit, with an average return of +14.90% per trade.
---